cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.
Company profile
Ticker
CRON
Exchange
Website
CEO
Kurt T. Schmidt
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
PharmaCan Capital Corp.
SEC CIK
Corporate docs
Subsidiaries
Hortican Inc. • Peace Naturals Project Inc. • Cronos Global Holdings Inc. • Cronos Canada Holdings Inc. • Original BC Ltd. • Cronos Research Labs Ltd. • Cronos Israel G.S. Store Ltd. • Cronos Israel G.S. Cultivation Ltd. • Cronos Israel G.S. Pharmacy Ltd. • Cronos Israel G.S. Manufacturing Ltd. ...
CRON stock data
Latest filings (excl ownership)
8-K
Changes in Registrant's Certifying Accountant
16 Apr 24
8-K
Departure of Directors or Certain Officers
3 Apr 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Cronos Group Reports 2023 Fourth Quarter and Full-Year Results1
29 Feb 24
8-K
Entry into a Material Definitive Agreement
27 Nov 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Cronos Group Reports 2023 Third Quarter Results
8 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
8-K
Cronos Group Reports 2023 Second Quarter Results
8 Aug 23
8-K
Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders
23 Jun 23
Transcripts
CRON
Earnings call transcript
2023 Q4
29 Feb 24
CRON
Earnings call transcript
2023 Q3
8 Nov 23
CRON
Earnings call transcript
2023 Q2
8 Aug 23
CRON
Earnings call transcript
2023 Q2
8 Aug 23
CRON
Earnings call transcript
2023 Q1
9 May 23
CRON
Earnings call transcript
2023 Q1
9 May 23
CRON
Earnings call transcript
2022 Q4
28 Feb 23
CRON
Earnings call transcript
2022 Q4
28 Feb 23
CRON
Earnings call transcript
2022 Q3
7 Nov 22
CRON
Earnings call transcript
2022 Q2
9 Aug 22
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 571.66 mm | 571.66 mm | 571.66 mm | 571.66 mm | 571.66 mm | 571.66 mm |
Cash burn (monthly) | (no burn) | 5.14 mm | 7.26 mm | 10.18 mm | 61.00 k | 7.00 mm |
Cash used (since last report) | n/a | 34.36 mm | 48.55 mm | 68.08 mm | 408.05 k | 46.84 mm |
Cash remaining | n/a | 537.30 mm | 523.10 mm | 503.58 mm | 571.25 mm | 524.82 mm |
Runway (months of cash) | n/a | 104.6 | 72.1 | 49.5 | 9364.7 | 75.0 |
Institutional ownership, Q3 2023
51.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 159 |
Opened positions | 30 |
Closed positions | 18 |
Increased positions | 40 |
Reduced positions | 31 |
13F shares | Current |
---|---|
Total value | 60.37 bn |
Total shares | 196.14 mm |
Total puts | 1.24 mm |
Total calls | 668.90 k |
Total put/call ratio | 1.9 |
Largest owners | Shares | Value |
---|---|---|
MO Altria | 156.57 mm | $446.24 mm |
Chesapeake Partners Management | 8.87 mm | $68.06 mm |
Chescapmanager | 8.33 mm | $16.65 bn |
Vanguard | 6.95 mm | $13.91 bn |
Dimensional Fund Advisors | 1.76 mm | $3.52 bn |
Intact Investment Management | 1.11 mm | $2.21 bn |
Millennium Management | 994.64 k | $1.99 bn |
Mirae Asset Global Investments | 866.17 k | $1.74 bn |
D. E. Shaw & Co. | 777.89 k | $1.55 bn |
Kerrisdale Advisers | 724.20 k | $1.45 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | Arye Weigensberg | COMMON SHARES | Option exercise | Acquire M | No | No | 0 | 24,237 | 0.00 | 52,211 |
15 Mar 24 | Arye Weigensberg | RSU COMMON SHARES | Option exercise | Dispose M | No | No | 0 | 24,237 | 0.00 | 147,770 |
15 Mar 24 | Anna Shlimak | COMMON SHARES | Payment of exercise | Dispose F | No | No | 1.98 | 11,799 | 23.36 k | 172,377 |
15 Mar 24 | Anna Shlimak | COMMON SHARES | Option exercise | Acquire M | No | No | 0 | 45,226 | 0.00 | 184,176 |
15 Mar 24 | Anna Shlimak | COMMON SHARES | Payment of exercise | Dispose F | No | No | 1.98 | 8,895 | 17.61 k | 138,950 |
15 Mar 24 | Anna Shlimak | COMMON SHARES | Option exercise | Acquire M | No | No | 0 | 30,000 | 0.00 | 147,845 |
15 Mar 24 | Anna Shlimak | RSU COMMON SHARES | Option exercise | Dispose M | No | No | 0 | 45,226 | 0.00 | 257,507 |
15 Mar 24 | Anna Shlimak | RSU COMMON SHARES | Option exercise | Dispose M | No | No | 0 | 30,000 | 0.00 | 302,733 |
15 Mar 24 | Jeffrey David Jacobson | COMMON SHARES | Payment of exercise | Dispose F | No | No | 1.98 | 23,509 | 46.55 k | 261,292 |
15 Mar 24 | Jeffrey David Jacobson | COMMON SHARES | Option exercise | Acquire M | No | No | 0 | 59,191 | 0.00 | 284,801 |
News
'Cannabis Seizures At Checkpoints By U.S.-Mexico Border Frustrates State-Authorized Pot Industry' - Audacy Citing AP
19 Apr 24
'Senator Presses Attorney General Garland On Marijuana Banking Bill's Impact On Criminal Investigations' - Marijuana Moment
17 Apr 24
'Marijuana Companies Ask Federal Court To Set Oral Arguments On DOJ Claim That Cannabis 'Tourism' Justifies Prohibition Enforcement' - Marijuana Moment
15 Apr 24
'FDA Head Says There's 'No Reason For DEA To Delay' Rescheduling Marijuana' - Marijuana Moment
11 Apr 24
Why Cronos Group Shares Are Falling
9 Apr 24
Press releases
Navigating the Growing Cannabis Stock Landscape in 2024
15 Apr 24
Cronos Launches Lord Jones® Chocolate Fusions
25 Mar 24
Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹
29 Feb 24
Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024
14 Feb 24
Cronos' Spinach® Brand Ends 2023 as the Number One Flower Brand in Canada1
25 Jan 24